Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy
Abstract Chronic hepatitis B virus (HBV) infection is the leading risk factor for hepatocellular carcinoma (HCC). The aim of this study was to explore the incidence of HCC in a cohort of subjects with HBV and correlate with HBV treatment current guidance. We identified 2846 subjects with HBV over th...
Main Authors: | Omar Alshuwaykh, Tami Daugherty, Amanda Cheung, Aparna Goel, Renumathy Dhanasekaran, T. Tara Ghaziani, Aijaz Ahmed, Deepti Dronamraju, Radhika Kumari, Allison Kwong, Mindie Nguyen, W. Ray Kim, Paul Yien Kwo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2022-11-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.2064 |
Similar Items
-
Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites
by: Omar Alshuwaykh, et al.
Published: (2022-09-01) -
Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation
by: Omar Alshuwaykh, et al.
Published: (2021-03-01) -
Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
by: Nia Adeniji, et al.
Published: (2021-12-01) -
Chinese Skullcap in Move Free Arthritis Supplement Causes Drug Induced Liver Injury and Pulmonary Infiltrates
by: Renumathy Dhanasekaran, et al.
Published: (2013-01-01) -
Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances [version 1; referees: 4 approved]
by: Renumathy Dhanasekaran, et al.
Published: (2016-05-01)